NEW YORK (GenomeWeb) – Biocept late on Monday priced its public offering of 8 million shares of its common stock and warrants to purchase up to 8 million shares of its stock. 

The combined offering price is $1.25 per share, the company said, adding the warrants have a per share exercise price of $1.56. The warrants are exercisable immediately and will expire five years from the date of issuance. Biocept anticipates gross proceeds of approximately $10 million from the offering. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Though many details have yet to be worked out, the draft deal for the UK's withdrawal from the EU is giving researchers some hints for what they can expect, Nature News says.

DNA testing has solved a 100-year-old mystery contained in the skull and teeth samples of a now-extinct monkey that once inhabited Jamaica, Gizmodo reports.

As the UN ponders a ban on gene drives, one malaria researcher says there are less dramatic ways to fight the disease in Africa than unleashing GM mosquitoes on a whole continent.

In Nature this week: an improved reference genome of the Aedes aegypti mosquito, genomes of four species of truffles, and more.